Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019

Raymund R. Razonable, John C. O'Horo, Douglas W. Challener, Lori Arndt, Richard F. Arndt, Caroline G. Clune, Tracy L. Culbertson, Scott T. Hall, Alexander Heyliger, Tammy A. Jackson, Brian D. Kennedy, Jennifer Larsen, Sara N. Hanson, Perry W. Sweeten, Sidna M. Tulledge-Scheitel, Ravindra Ganesh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019'. Together they form a unique fingerprint.

Medicine & Life Sciences